Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 17075429)

Published in Menopause on April 03, 2007

Authors

Andrea Riccardo Genazzani1, Nicola Pluchino, Silvia Begliuomini, Matteo Pieri, Manolo Centofanti, Letizia Freschi, Elena Casarosa, Michele Luisi

Author Affiliations

1: Department of Reproductive Medicine and Child Development, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy. a.genazzani@obgyn.med.unipi.it

Articles by these authors

Estrogen, cognition and female ageing. Hum Reprod Update (2006) 1.78

Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol (2008) 1.08

Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology (2010) 0.98

Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. PLoS One (2012) 0.95

Endocrinology of menopausal transition and its brain implications. CNS Spectr (2005) 0.93

Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertil Steril (2004) 0.90

Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol (2011) 0.88

Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF. J Assist Reprod Genet (2008) 0.88

Comparison of the initial surgical experience with robotic and laparoscopic myomectomy. Int J Med Robot (2013) 0.88

Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol (2006) 0.85

Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology (2002) 0.84

Endometriosis-Associated Abdominal Wall Cancer: A Poor Prognosis? Int J Gynecol Cancer (2015) 0.84

Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res (2003) 0.83

Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril (2003) 0.83

Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology (2006) 0.82

Sexual hormone serum levels and temporomandibular disorders. A preliminary study. Gynecol Endocrinol (2005) 0.81

Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin. Fertil Steril (2005) 0.81

Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol (2002) 0.81

Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology (2010) 0.80

Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol (2006) 0.80

Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause (2008) 0.80

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol (2007) 0.80

Androgens and the brain. Maturitas (2007) 0.80

Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects. Int J Eat Disord (2003) 0.80

Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause (2006) 0.80

Effects of nomegestrol acetate administration on central and peripheral beta-endorphin and allopregnanolone in ovx rats. J Steroid Biochem Mol Biol (2008) 0.79

Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells. Maturitas (2011) 0.79

Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: effects on central and peripheral allopregnanolone and beta-endorphin. Maturitas (2002) 0.79

Sexually dimorphic effects of testosterone administration on brain allopregnanolone in gonadectomized rats. J Sex Med (2008) 0.79

Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels. Gynecol Endocrinol (2007) 0.78

Paroxetine increases brain-derived neurotrophic factor in postmenopausal women. Menopause (2010) 0.78

Subtotal versus total laparoscopic hysterectomy: could women sexual function recovery overcome the surgical outcomes in pre-operatory decision making? Arch Gynecol Obstet (2014) 0.78

Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats. Fertil Steril (2007) 0.77

One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. Maturitas (2008) 0.76

Clinical evaluation of patients with weight loss-related amenorrhea: neuropeptide Y and luteinizing hormone pulsatility. Gynecol Endocrinol (2006) 0.76

Effects of the new generation selective estrogen receptor modulator EM-652 and oral administration of estradiol valerate on circulating, brain, and adrenal beta-endorphin and allopregnanolone levels in intact fertile and ovariectomized rats. Fertil Steril (2002) 0.76

Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women. Neuropsychiatr Dis Treat (2006) 0.76

Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecol Endocrinol (2010) 0.76

Sex differences in brain and plasma beta-endorphin content following testosterone, dihydrotestosterone and estradiol administration to gonadectomized rats. Neuroendocrinology (2009) 0.76

Diurnal Variation of Plasma Brain-Derived Neurotrophic Factor Levels in Women with Functional Hypothalamic Amenorrhea. Neuroendocrinology (2015) 0.76

Brain-derived neurotrophic factor plasma levels in patients with Turner syndrome. Gynecol Endocrinol (2014) 0.76

Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats. Menopause (2009) 0.75

Menopausal hot flashes: still an undiscovered territory. Menopause (2009) 0.75

Behavioral, psycho-physiological and salivary cortisol modifications after short-term alprazolam treatment in patients with recent myocardial infarction. Ital Heart J (2002) 0.75

Decreased plasma concentrations of brain-derived neurotrophic factor (BDNF) in patients with functional hypothalamic amenorrhea. Gynecol Endocrinol (2013) 0.75

Robotic-assisted laparoscopic surgery in uterine pathology. Eur J Obstet Gynecol Reprod Biol (2013) 0.75

Selective effect of chlormadinone acetate on brain allopregnanolone and opioids content. Contraception (2009) 0.75

Raloxifene treatment increases plasma levels of beta-endorphin in postmenopausal women: a randomized, placebo-controlled study. Fertil Steril (2002) 0.75

A Novel System for Single-Port Laparoscopic Surgery: Preliminary Experience. Gynecol Obstet Invest (2016) 0.75

The fetal brain: role of progesterone and allopregnanolone. Horm Mol Biol Clin Investig (2016) 0.75

Is vaginal administration the "way out" of the hormone of controversy? Menopause (2016) 0.75

Effect of Growth Hormone on Endometrial Thickness and Fertility Outcome in the Treatment of Women with Panhypopituitarism: A Case Report. J Reprod Med (2016) 0.75